Literature DB >> 15731028

Susceptibility of germfree phagocyte oxidase- and nitric oxide synthase 2-deficient mice, defective in the production of reactive metabolites of both oxygen and nitrogen, to mucosal and systemic candidiasis of endogenous origin.

Edward Balish1, Thomas F Warner, Peter J Nicholas, Emily E Paulling, Caroline Westwater, David A Schofield.   

Abstract

Mice deficient for phagocyte oxidase (Phox) and nitric oxide synthase 2 (NOS2) (gp91phox-/-/NOS2-/-), defective in the production of both reactive oxygen intermediates (ROI) and reactive nitrogen intermediates (RNI), were used to investigate the role of phagocytic cells during mucosal and systemic candidiasis of endogenous origin. The alimentary tracts of germfree mice were colonized with Candida albicans wild type or each of two hyphal signaling-defective mutants (efg1/efg1 and efg1/efg1 cph1/cph1). All Candida-colonized gp91phox-/-/NOS2-/- mice were moribund within 12 to 15 days after oral inoculation. C. albicans wild-type and mutant strains colonized the alimentary tracts equally well and were able to translocate, most likely via Peyer's patches and mesenteric lymph nodes, to the internal organs and trigger the formation of abscesses; however, the wild-type and mutant strains did not survive in the abscessed murine tissues. Surprisingly, there was no significant difference in the ability of peritoneal exudate cells from gp91phox-/-/NOS2-/-, NOS2-/-, gp91phox-/-, or immunocompetent C57BL/6 mice to kill C. albicans in vitro. This suggests that anti-Candida factors other than ROI and RNI can control the growth of C. albicans and that gp91phox-/-/NOS2-/- mice die due to the inability of the host to control its inflammatory response to Candida. Correspondingly, reverse transcription-PCR analysis showed increased expression of the cytokines gamma interferon, tumor necrosis factor alpha, and the chemokines MIP-2 and KC at the site of infection, while interleukin-15 expression remained relatively unchanged between germfree and infected tissues. These studies indicate that defects in ROI and RNI enabled C. albicans to translocate and disseminate to the internal organs, resulting in an uncontrolled immune response, severe pathology, and death; however, ROI and RNI were not required for the killing of phagocytized C. albicans, indicating that other anti-Candida factors either compensate or are sufficient for the killing of phagocytized Candida.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15731028      PMCID: PMC1064974          DOI: 10.1128/IAI.73.3.1313-1320.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

Review 1.  Biochemical mechanisms of intracellular killing of fungi.

Authors:  K Kagaya; K Watanabe; Y Fukazawa; S Suzuki; M Kobayashi; Y Okawa; M Suzuki; H Takahashi; E Brummer; N Kurita
Journal:  J Med Vet Mycol       Date:  1992

2.  Oroesophageal candidiasis is lethal for transgenic mice with combined natural killer and T-cell defects.

Authors:  E Balish; T Warner; C J Pierson; D M Bock; R D Wagner
Journal:  Med Mycol       Date:  2001-06       Impact factor: 4.076

3.  Simultaneous cytofluorometric measurement of phagocytosis, burst production and killing of human phagocytes using Candida albicans and Staphylococcus aureus as target organisms.

Authors:  H R Salih; L Husfeld; D Adam
Journal:  Clin Microbiol Infect       Date:  2000-05       Impact factor: 8.067

4.  Impaired pulmonary NF-kappaB activation in response to lipopolysaccharide in NADPH oxidase-deficient mice.

Authors:  M A Koay; J W Christman; B H Segal; A Venkatakrishnan; T R Blackwell; S M Holland; T S Blackwell
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

5.  Suppression of type 2 NO-synthase activity in macrophages by Candida albicans.

Authors:  K Schröppel; M Kryk; M Herrmann; E Leberer; M Röllinghoff; C Bogdan
Journal:  Int J Med Microbiol       Date:  2001-03       Impact factor: 3.473

6.  Differential host susceptibility to pulmonary infections with bacteria and fungi in mice deficient in myeloperoxidase.

Authors:  Y Aratani; F Kura; H Watanabe; H Akagawa; Y Takano; K Suzuki; N Maeda; H Koyama
Journal:  J Infect Dis       Date:  2000-09-06       Impact factor: 5.226

7.  Essential role of the Candida albicans transglutaminase substrate, hyphal wall protein 1, in lethal oroesophageal candidiasis in immunodeficient mice.

Authors:  Paula Sundstrom; Edward Balish; Carl M Allen
Journal:  J Infect Dis       Date:  2002-01-31       Impact factor: 5.226

8.  Reintroduction of the PLB1 gene into Candida albicans restores virulence in vivo.

Authors:  Pranab K Mukherjee; K R Seshan; S D Leidich; Jyotsna Chandra; Garry T Cole; Mahmoud A Ghannoum
Journal:  Microbiology (Reading)       Date:  2001-09       Impact factor: 2.777

9.  Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study.

Authors:  D J Diekema; S A Messer; A B Brueggemann; S L Coffman; G V Doern; L A Herwaldt; M A Pfaller
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

10.  Critical role of myeloperoxidase and nicotinamide adenine dinucleotide phosphate-oxidase in high-burden systemic infection of mice with Candida albicans.

Authors:  Yasuaki Aratani; Fumiaki Kura; Haruo Watanabe; Hisayoshi Akagawa; Yukie Takano; Kazuo Suzuki; Mary C Dinauer; Nobuyo Maeda; Hideki Koyama
Journal:  J Infect Dis       Date:  2002-05-16       Impact factor: 5.226

View more
  18 in total

Review 1.  Candida albicans Pathogenesis: Fitting within the Host-Microbe Damage Response Framework.

Authors:  Mary Ann Jabra-Rizk; Eric F Kong; Christina Tsui; M Hong Nguyen; Cornelius J Clancy; Paul L Fidel; Mairi Noverr
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

Review 2.  Beyond Candida albicans: Mechanisms of immunity to non-albicans Candida species.

Authors:  Natasha Whibley; Sarah L Gaffen
Journal:  Cytokine       Date:  2015-08-11       Impact factor: 3.861

Review 3.  Murine models of Candida gastrointestinal colonization and dissemination.

Authors:  Andrew Y Koh
Journal:  Eukaryot Cell       Date:  2013-09-13

4.  Candida albicans induces arginine biosynthetic genes in response to host-derived reactive oxygen species.

Authors:  Claudia Jiménez-López; John R Collette; Kimberly M Brothers; Kelly M Shepardson; Robert A Cramer; Robert T Wheeler; Michael C Lorenz
Journal:  Eukaryot Cell       Date:  2012-11-09

5.  Live imaging of disseminated candidiasis in zebrafish reveals role of phagocyte oxidase in limiting filamentous growth.

Authors:  Kimberly M Brothers; Zachary R Newman; Robert T Wheeler
Journal:  Eukaryot Cell       Date:  2011-05-06

6.  Candida albicans biofilms do not trigger reactive oxygen species and evade neutrophil killing.

Authors:  Zhihong Xie; Angela Thompson; Takanori Sobue; Helena Kashleva; Hongbin Xu; John Vasilakos; Anna Dongari-Bagtzoglou
Journal:  J Infect Dis       Date:  2012-10-02       Impact factor: 5.226

7.  Effect of Antifungal Treatment in a Diet-Based Murine Model of Disseminated Candidiasis Acquired via the Gastrointestinal Tract.

Authors:  David Kadosh; Laura K Najvar; Rosie Bocanegra; Marcos Olivo; William R Kirkpatrick; Nathan P Wiederhold; Thomas F Patterson
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

8.  Live Candida albicans suppresses production of reactive oxygen species in phagocytes.

Authors:  Melanie Wellington; Kristy Dolan; Damian J Krysan
Journal:  Infect Immun       Date:  2008-11-03       Impact factor: 3.441

9.  Normal adaptation of Candida albicans to the murine gastrointestinal tract requires Efg1p-dependent regulation of metabolic and host defense genes.

Authors:  Jessica V Pierce; Daniel Dignard; Malcolm Whiteway; Carol A Kumamoto
Journal:  Eukaryot Cell       Date:  2012-11-02

10.  Detrimental role of endogenous nitric oxide in host defence against Sporothrix schenckii.

Authors:  Karla Simone S Fernandes; Edward Helal Neto; Marcelly M S Brito; João S Silva; Fernando Q Cunha; Christina Barja-Fidalgo
Journal:  Immunology       Date:  2008-01-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.